The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

A study of more than 2 million Veterans Health Administration patient records found GLP-1 drugs lowered the likelihood of ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites, may not be very high on the list of things demanding c-store retailers’ attention. But that ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...